Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery

计划入组 29 人 · 首次发布于 2009 年 2 月 6 日

Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)

计划入组 10 人 · 首次发布于 2010 年 4 月 9 日

Endothelin-1 as a Potential Trigger of Migraine Aura

计划入组 60 人 · 首次发布于 2016 年 9 月 19 日

Endothelin Type A Receptor Antagonist (St Johns University)

Ambrisentan(Letairis, Volibris, Ambrisentan Mylan, Ambrisentan Viatris (previously Ambrisentan Mylan))

C₂₂H₂₂N₂O₄ · Rx

Endothelin-1

A&A SMALL CHANGES HANDYPEOPLE

United States

Novozymes A/S

Denmark

Ambu A/S

Denmark

BioCity's SC0062 Receives Breakthrough Therapy Designation for IgA Nephropathy

EMA Panel Recommends Sparsentan for IgA Nephropathy, Paving Way for EU Approval

Atrasentan Shows Promise in Reducing Proteinuria in IgA Nephropathy